<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129568">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02080676</url>
  </required_header>
  <id_info>
    <org_study_id>CMC-14-0001-CTIL</org_study_id>
    <nct_id>NCT02080676</nct_id>
  </id_info>
  <brief_title>Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow</brief_title>
  <official_title>Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carmel Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carmel Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of study: to check the effect of medical cannabis given for approved medical
      indications on ocular parameters including intra ocular pressure, optic nerve fibers
      thickness and choroidal thickness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of study: to check the effect of medical cannabis given for approved medical
      indications on ocular parameters including intra ocular pressure, Retinal Nerve Fiber Layer
      (RNFL) thickness, optic nerve fibers thickness and choroidal thickness.

      Adult patients with no ocular pathology that are being treated in the neurology or pain
      clinics with medical cannabis for different indications, were examined in the eye clinic.

      First examination took place after the patient was not smoking for 5 hours. Three more
      examinations took place 1 hour 3 hours and 5 hours after smoking cannabis.

      The following parameters were checked: blood pressure, pulse, visual acuity, intra ocular
      pressure, corneal thickness, axial length, slit lamp examination of anterior segment,
      fundoscopy and Optical Coherence Tomography (OCT) of the retina, and optic nerve.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Intra ocular pressure</measure>
    <time_frame>5 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intra Ocular Pressure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients over the age of 18,  with no ocular pathology that are being treated in the
        neurology or pain clinics with medical cannabis for different indications.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18

          -  Treated with medical cannabis for approved medical indications

        Exclusion Criteria:

          -  Known ocular pathology

          -  Topical or systemic treatment for intra ocular pressure

          -  Previous topical, intra ocular or systemic steroid treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orna Geyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carmel Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orna Geyer, MD</last_name>
    <phone>97248250926</phone>
    <email>orna_geyer@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nurit Mathalone, MD</last_name>
      <phone>97248250477</phone>
      <email>Nurit.Mathalone@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Orna Geyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>March 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Carmel Medical Center</investigator_affiliation>
    <investigator_full_name>Orna Geyer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cannabis</keyword>
  <keyword>Intra ocular pressure</keyword>
  <keyword>Ocular perfusion</keyword>
  <keyword>Blood pressure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Marijuana Smoking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
